ALBEMARLE CORP (ALB-PA)

Latest 10-K (filed 2026-03-31)

Income Statement

Consolidated Statement of Income

ALBEMARLE CORPORATION (ALB PR A)

Year Ended (In thousands, except shares and per share data)

Dec 31, 2025 Dec 31, 2024 Dec 31, 2023
  Revenues $5,142,733 $5,377,526 $9,617,203
Unconsolidated Affiliates $16,344 $30,090 $35,676
  Cost of goods sold $4,474,014 $5,314,987 $8,431,294
Related Party $534,000 $1,700,000 $2,300,000
    Gross profit $668,719 $62,539 $1,185,909
    Selling, general and administrative expenses $550,036 $618,048 $910,002
    Goodwill impairment $181,070
    Long-lived asset impairment charges $245,600
    Restructuring charges and asset write-offs $7,699 $1,134,316 $9,491
Selling, general and administrative expenses $2,200
Other income, net $26,100
    Research and development expenses $51,398 $86,720 $85,725
    Gain on change in interest in properties/sale of business, net $(71,190)
    Operating (loss) profit $(367,084) $(1,776,545) $251,881
    Interest and financing expenses $(207,651) $(165,619) $(116,072)
    Other income, net $22,662 $178,339 $110,929
    (Loss) income before income taxes and equity in net income of unconsolidated investments $(552,073) $(1,763,825) $246,738
    Income tax expense $156,881 $87,085 $430,277
  Loss before equity in net income of unconsolidated investments $(708,954) $(1,850,910) $(183,539)
  Equity in net income of unconsolidated investments (net of tax) $243,744 $715,433 $1,854,082
    Net (loss) income $(465,210) $(1,135,477) $1,670,543
    Net income attributable to noncontrolling interests $(45,418) $(43,972) $(97,067)
    Net (loss) income attributable to Albemarle Corporation (510,628) (1,179,449) 1,573,476
    Mandatory convertible preferred stock dividends $(166,750) $(136,647)
    Net (loss) income attributable to Albemarle Corporation common shareholders, basic (677,378) (1,316,096) 1,573,476
  Net (loss) income attributable to Albemarle Corporation common shareholders, diluted (677,378) (1,316,096) 1,573,476
  Basic earnings (loss) per share attributable to common shareholders (in dollars per share) -5.76 -11.20 13.41
  Diluted earnings (loss) per share attributable to common shareholders (in dollars per share) -5.76 -11.20 13.36
  Weighted-average common shares outstanding—basic (in shares) 117,664 117,516 117,317
  Weighted-average common shares outstanding—diluted (in shares) 117,664 117,516 117,766

Balance Sheet

Consolidated Balance Sheets

ALBEMARLE CORPORATION (ALB PR A)

As of December 31, 2025 and December 31, 2024 (In thousands, except shares and per share data)

Dec 31, 2025 Dec 31, 2024
          Cash and cash equivalents $1,618,001 $1,192,230
          Trade accounts receivable, less allowance for credit losses (2025—$4,578; 2024—$5,201) $593,502 $742,201
          Other accounts receivable $105,110 $238,384
          Inventories $1,179,271 $1,502,531
          Other current assets $140,440 $166,916
          Current assets held for sale $371,815
            Total current assets $4,008,139 $3,842,262
          Property, plant and equipment, at cost $11,768,840 $12,523,368
          Less accumulated depreciation and amortization $3,156,429 $3,191,898
        Net property, plant and equipment $8,612,411 $9,331,470
        Investments $900,926 $1,117,739
        Other assets $647,185 $504,711
        Goodwill $1,499,657 $1,582,714
        Other intangibles, net of amortization $214,233 $230,753
        Noncurrent assets held for sale $491,660
        Total assets $16,374,211 $16,609,649
          Accounts payable $913,529 $943,887
Nonrelated Party $779,160 $793,455
Related Party $134,369 $150,432
          Accrued expenses $521,831 $467,997
          Current portion of long-term debt $74,077 $398,023
          Dividends payable $61,387 $61,282
          Income taxes payable $35,467 $95,275
          Current liabilities held for sale $191,753
          Total current liabilities $1,798,044 $1,966,464
          Long-term debt $3,119,464 $3,118,142
          Postretirement benefits $44,744 $31,930
          Pension benefits $117,361 $116,192
          Other noncurrent liabilities $1,084,892 $819,204
          Deferred income taxes $368,275 $358,029
          Noncurrent liabilities held for sale $59,970
          Commitments and contingencies
              Common stock, $.01 par value (authorized 275,000 shares), issued and outstanding — 117,716 in 2025 and 117,560 in 2024 $1,178 $1,176
              Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized - 15,000, issued and outstanding - 2,300 in 2025 and 2024 $2,235,105 $2,235,105
              Additional paid-in capital $3,018,213 $2,985,606
              Accumulated other comprehensive loss $(334,807) $(742,062)
              Retained earnings $4,613,676 $5,481,692
              Total Albemarle Corporation shareholders’ equity 9,533,365 9,961,517
          Noncontrolling interests $248,096 $238,171
          Total equity $9,781,461 $10,199,688
        Total liabilities and equity $16,374,211 $16,609,649

Cash Flow

Consolidated Statement of Cash Flows

ALBEMARLE CORPORATION (ALB PR A)

Year Ended (In thousands, except shares and per share data)

Dec 31, 2025 Dec 31, 2024 Dec 31, 2023
      Cash and cash equivalents at end of year
        Net (loss) income $(465,210) $(1,135,477) $1,670,543
            Depreciation and amortization $658,678 $588,638 $429,944
            Non-cash goodwill impairment charges $181,070
            Non-cash long-lived asset impairment charges $245,600
            Non-cash restructuring and asset write-offs $1,013,444
            Gain on change in interest in properties/sale of business, net $(71,190)
            Stock-based compensation and other $40,271 $32,141 $36,545
            Equity in net income of unconsolidated investments (net of tax) $(243,744) $(715,433) $(1,854,082)
            Dividends received from unconsolidated investments and nonmarketable securities $93,739 $358,933 $2,000,862
            Pension and postretirement expense (benefit) $23,377 $(5,274) $(1,658)
            Pension and postretirement contributions $(20,441) $(19,379) $(17,866)
            Realized loss on investments in marketable securities $33,746
            Unrealized (gain) loss on investments in marketable securities $(14,088) $30,073 $39,864
            Loss on early extinguishment of debt $7,471
            Deferred income taxes $81,169 $(230,406) $100,877
            Decrease (increase) in accounts receivable $47,315 $555,218 $(350,655)
            Decrease (increase) in inventories $212,351 $1,055,036 $(353,564)
            Decrease (increase) in other current assets $4,027 $244,987 $(171,870)
            Increase (decrease) in accounts payable to third parties $128,145 $(862,237) $(283,411)
Nonrelated Party $144,208 $(462,839) $(315,220)
Related Party $(16,063) $(399,398) $31,809
            (Decrease) increase in accrued expenses and income taxes payable $(36,753) $(140,099) $253,518
            Noncurrent liability changes and other, net $339,290 $(116,035) $(101,274)
        Net cash provided by operating activities $1,282,267 $687,876 $1,326,583
        Acquisitions, net of cash acquired $(426,228)
        Capital expenditures $(589,801) $(1,680,529) $(2,154,542)
        Proceeds from sale of property and equipment $32,812 $29,102
        Proceeds from sale from investments $290,908
        Proceeds (payments) from settlement of foreign currency forward contracts, net $114,236 $(15,595) $221,849
        Sales (purchases) of marketable securities, net $6,077 $82,520 $(204,451)
        Investments in equity investments and nonmarketable securities $(239) $(270) $(1,200)
        Net cash used in investing activities $(146,007) $(1,584,772) $(2,564,572)
          Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs $2,236,750
          Proceeds from borrowings of long-term debt and credit agreements $56,728 $112,439 $356,047
          Repayments of long-term debt and credit agreements $(505,736) $(112,439) $(28,862)
          Other (repayments) borrowings, net $(5,657) $(631,834) $617,014
          Dividends paid to common shareholders $(190,530) $(188,530) $(187,188)
          Dividends paid to mandatory convertible preferred shareholders $(166,750) $(122,746)
          Dividends paid to noncontrolling interests $(18,169) $(37,194) $(105,631)
          Proceeds from exercise of stock options $3,240 $374 $190
          Withholding taxes paid on stock-based compensation award distributions $(7,258) $(11,891) $(27,468)
          Other $(55) $(3,194) $(191)
        Net cash (used in) provided by financing activities $(834,187) $1,241,735 $623,911
        Net effect of foreign exchange on cash and cash equivalents $123,698 $(42,509) $4,836
      Increase (decrease) in cash and cash equivalents $425,771 $302,330 $(609,242)
      Cash and cash equivalents at end of year